The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patient-reported outcomes (PROs) from the DREAMM-7 randomized phase 3 study comparing belantamab mafodotin, bortezomib, and dexamethasone (BVd) vs daratumumab, bortezomib, and dexamethasone (DVd) in patients with relapsed/refractory multiple myeloma (RRMM).
 
Vania Hungria
Consulting or Advisory Role - Abbvie; Amgen; BMS Brazil; GlaxoSmithKline; Janssen-Cilag; Pfizer; Regeneron; Sanofi; Takeda
Speakers' Bureau - Abbvie; Amgen; BMS Brazil; GlaxoSmithKline; Janssen-Cilag; Pfizer; Sanofi; Takeda
 
Pawel Robak
No Relationships to Disclose
 
Marek Hus
No Relationships to Disclose
 
Chengcheng Fu
Consulting or Advisory Role - Takeda China) International Trading Co, Ltd
Speakers' Bureau - Takeda China) International Trading Co, Ltd
 
Vera Zherebtsova
No Relationships to Disclose
 
Christopher Ward
Leadership - Education Chair, International Society of Thrombosis and Haemostasis Annual Congress Planning Committee Chair, 2024
Honoraria - AstraZeneca; Bayer; Drivetime Radio
Speakers' Bureau - AstraZeneca; Bayer
 
Ana Carolina de Almeida
No Relationships to Disclose
 
P. Joy Ho
Consulting or Advisory Role - Australasian Leukemia & Lymphoma Group trials
Research Funding - Novartis
(OPTIONAL) Uncompensated Relationships - Antengene; Gilead Sciences; iTEOS Therapeutics; Janssen; Pfizer
 
Roman Hajek
Honoraria - Amgen; BMS Brazil; Celgene; Janssen; PharmaMar; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; PharmaMar; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Janssen; PharmaMar; Takeda
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Janssen (Inst); Novartis (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Amgen; Celgene; Janssen; Takeda
 
Claudio Cerchione
Honoraria - Abbvie; Amgen; BeiGene; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Menarini; Pfizer; Sanofi/Aventis; SERVIER; Stemline Therapeutics; Takeda
Consulting or Advisory Role - Abbvie; Amgen; BeiGene; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Menarini; Pfizer; Sanofi; SERVIER; Stemline Therapeutics; Takeda
Speakers' Bureau - Abbvie; Amgen; BeiGene; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Menarini; Pfizer; Sanofi/Aventis; SERVIER; Stemline Therapeutics; Takeda
 
Nicholas Pirooz
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Astrid McKeown
Employment - Charles River Analytics (I); GlaxoSmithKline
Stock and Other Ownership Interests - AstraZeneca; GlaxoSmithKline; GlaxoSmithKline (I); HALEON; HALEON (I); Novartis; Novartis (I)
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Hena Baig
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Lydia Eccersley
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Farrah Pompilus
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Simon McNamara
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Chee Paul Lin
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Sumita Roy-Ghanta
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Joanna Opalinska
Employment - GlaxoSmithKline
Leadership - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
Patents, Royalties, Other Intellectual Property - Blenrep related patents
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Maria-Victoria Mateos
Honoraria - Abbvie/Genentech; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Pfizer; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Kite, a Gilead company; Pfizer; Regeneron; Roche/Genentech; Stemline Therapeutics; Takeda